Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-005693
Filing Date
2023-02-21
Accepted
2023-02-21 16:31:55
Documents
1
Period of Report
2023-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6197
  Complete submission text file 0000899243-23-005693.txt   7732
Mailing Address C/O VITAE PHARMACEUTICLS, INC. 502 WEST OFFICE CENTER DRIVE FORT WASHINGTON PA 19034
Business Address
Bernstein Karen (Reporting) CIK: 0001654055 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39615 | Film No.: 23648700

Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Issuer) CIK: 0001659352 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)